XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Treasury shares
Own shares held by ESOP
Retained earnings
Accumulated other comprehensive loss
Ordinary shares
Ordinary shares
Common stock
Deferred shares
Deferred shares
Common stock
Beginning balance at Dec. 31, 2017 $ 174.5   $ 62.1 $ (5.8) $ (1.0) $ 83.7 $ (140.7)   $ 25.3   $ 150.9
Beginning balance (in shares) at Dec. 31, 2017       (500,000) (100,000)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 25.0         25.0          
Issue of new shares (in shares)         (1,900,000)            
Issue of new shares 0.0 $ 1.3     $ (1.3)            
Cancellation of deferred shares 0.0 $ (1.0) 1.0                
Shares sold from ESOP (in shares)         500,000            
Shares sold from ESOP 6.6   6.2   $ 0.4            
Other comprehensive loss, net of tax (5.9)           (5.9)        
Dividends declared and paid (13.4)         (13.4)          
Share based compensation (2.5)   (2.5)                
Purchase of shares into ESOP (in shares)       100,000 100,000            
Purchase of shares into ESOP 0.0     $ 1.4 $ (1.4)            
Utilization of treasury shares to satisfy share based compensation 0.0   (0.1) 0.1              
Utilization of shares from ESOP to satisfy share based compensation 0.0   (1.1)   1.1            
Ending balance at Dec. 31, 2018 184.3   65.6 $ (4.3) $ (2.2) 95.3 (146.6)   26.6   149.9
Ending balance (in shares) at Dec. 31, 2018       (400,000) (1,600,000)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 3.1         3.1          
Shares sold from ESOP (in shares)         200,000            
Shares sold from ESOP 3.5   3.3   $ 0.2            
Other comprehensive loss, net of tax (3.0)           (3.0)        
Dividends declared and paid (13.6)         (13.6)          
Share based compensation 4.1   4.1                
Utilization of treasury shares to satisfy share based compensation 0.2   (0.1) $ 0.3              
Utilization of shares from ESOP to satisfy share based compensation (4.2)   (4.5)   $ 0.3            
Utilization of shares from ESOP to satisfy share based compensation (in shares)         200,000            
Ending balance at Dec. 31, 2019 174.4   68.4 $ (4.0) $ (1.7) 84.8 (149.6)   26.6   149.9
Ending balance (in shares) at Dec. 31, 2019       (400,000) (1,200,000)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 20.0         20.0          
Shares sold from ESOP (in shares)         100,000     70,799   0  
Shares sold from ESOP 1.1   0.8   $ 0.3            
Other comprehensive loss, net of tax (16.2)           (16.2)        
Dividends declared and paid (13.6)         (13.6)          
Share based compensation 2.8   2.8                
Utilization of treasury shares to satisfy share based compensation (0.1)   (0.1)                
Utilization of shares from ESOP to satisfy share based compensation (1.3)   (1.3)                
Utilization of shares from ESOP to satisfy share based compensation (in shares)         100,000            
Ending balance at Dec. 31, 2020 $ 167.1   $ 70.6 $ (4.0) $ (1.4) $ 91.2 $ (165.8)   $ 26.6   $ 149.9
Ending balance (in shares) at Dec. 31, 2020       (400,000) (1,000,000.0)